A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care
Hence then, the article about immunotherapy drug delays cancer recurring or worsening in global trial was published today ( ) and is available on Independent ( Yemen ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy drug delays cancer recurring or worsening in global trial )
Last updated :
Also on site :
- ‘What the hell?’: Charlotte woman tries on clothes at H&M. Then she notices a phone hanging above the door—and someone’s hand
- Christmas leftovers meet Italian flair: Three recipes to reinvent festive staples
- Soul and Love exhibition: A journey into Coptic heritage at the National Museum of Egyptian Civilization